Portfolio company
Kopra Bio
Country not known yet
Raised
Not known yet
Latest stage
Not known yet
Rounds recorded
Not known yet
Backed by
2 investors
Sectors
About
The company develops cancer immunotherapies that engineer cancer cells to produce therapeutic agents for patients, within the deep-tech and digital-health sectors.
SourceFunding history · 0
No rounds recorded yet. The agent looks for them over time.
Similar companies
DualTPharma
This company develops bacteria-based drug delivery systems to transport immunotherapies into solid tumours for cancer patients.
Bioarchitech
This company develops viral and RNA immunotherapies designed to help the immune systems of cancer patients target and destroy tumours.
Laguna Bio
This company develops engineered microbial therapies that activate the immune system to treat cancer patients.
Vivere Oncotherapies
This company develops engineered cancer immunotherapies to help the immune systems of patients with solid tumours detect and destroy malignant cells.
Captain T Cell
The company develops cell therapies for cancer patients to treat solid tumours.
OverT
This biotechnology company develops engineered cell therapies for the treatment of solid tumours in cancer patients.
Ancilia Bio
The company develops CRISPR-engineered bacterial therapies with viral immunity for the biopharmaceutical and healthcare sectors.
Neobe
The company develops engineered microbial biotherapeutics designed to disrupt the microenvironment of solid tumours for cancer patients receiving immunotherapy.